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Controlling arterial carbon dioxide is paramount in mechanically ventilated patients, and an 38 
accurate and continuous noninvasive monitoring method would optimize management in 39 
dynamic situations. In this study, we validated and further refined formulas for estimating 40 
partial pressure of carbon dioxide with respiratory gas and pulse oximetry data in 41 
mechanically ventilated cardiac arrest patients.  42 
Methods 43 
 A total of 4,741 data sets were collected retrospectively from 233 resuscitated patients 44 
undergoing therapeutic hypothermia. The original formula used to analyze the data is 45 
PaCO2-est1= PETCO2+k(PIO2-PETCO2) -PaO2. To achieve better accuracy, we further 46 
modified the formula to PaCO2-est2= k1*PETCO2 + k2*(PIO2-PETCO2)+k3*(100-SpO2). The 47 
coefficients were determined by identifying the minimal difference between the measured 48 
and calculated arterial carbon dioxide values in a development set. The accuracy of these 49 
two methods was compared with the estimation of the partial pressure of carbon dioxide 50 
using end-tidal carbon dioxide.  51 
Results 52 
With PaCO2-est1, the mean difference between the partial pressure of carbon dioxide, and 53 
the estimated carbon dioxide was 0.08 kPa (SE ± 0.003); with PaCO2-est2 the difference was 54 
0.036 kPa (SE ± 0.009). The mean difference between the partial pressure of carbon dioxide 55 
and end-tidal carbon dioxide was 0.72 kPa (SE ± 0.01). In a mixed linear model, there was a 56 
significant difference between the estimation using end-tidal carbon dioxide and PaCO2-est1 57 
(p<0.001) and PaCO2-est2 (p<0.001), respectively.  58 
Conclusions 59 
This novel formula appears to provide an accurate, continuous, and noninvasive estimation 60 








Monitoring carbon dioxide is paramount in mechanically ventilated patients and commonly 67 
performed by measuring the partial pressure of carbon dioxide (PaCO2) with arterial blood 68 
gas (ABG) analysis. Although an ABG analysis intermittently provides exact PaCO2 values, 69 
PaCO2 may change despite constant ventilation.   70 
End-tidal carbon dioxide generally underestimates arterial PaCO2. 1 End-tidal carbon 71 
dioxide is affected by the ventilation/perfusion ratio (V/Q ratio), possible cardiac disease 72 
such as right-to-left shunt, and increased dead space .2 Maintaining normoventilation may 73 
be difficult under circumstances where ABG measurements is not available, including 74 
prehospital care and patient transport. 3 The measurement of PETCO2 with continuous 75 
capnography is used as a surrogate but may be a poor indicator of PaCO2 because of V/Q 76 
mismatch. Dyscarbia and unintentional deviation from normoventilation have been 77 
associated with poor outcome. 4-5 Therefore, seeking new dynamic methods to 78 
noninvasively estimate PaCO2 is highly important.6  79 
We present a method for estimating the PaCO2 level in a continuous and noninvasive 80 
way. Previously, we tested a formula for estimating arterial carbon dioxide partial pressures 81 
in an experimental model and found good agreement between this formula with measured 82 
PaCO2 values in various physiological and pathophysiological conditions. 7 The formula was 83 
developed based on the assumption that the degree of V/Q mismatch  behind the alveolar–84 
arterial oxygen tension difference (PA-aO2) is similar for both O2 and CO2. In our  previous 85 
study, the estimation of PaO2 was evaluated purely under experimental conditions. The 86 
primary aim of the present study was to test the agreement of measured PaCO2 and 87 
estimated PaCO2 by the original formula in mechanically ventilated cardiac arrest (CA) 88 
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patients. The secondary aim was to validate and refine this formula to achieve a better 89 
agreement. In addition, we studied whether the accuracy of the current formulas was 90 























Study subjects and settings  112 
We conducted a retrospective study in mechanically ventilated adult (≥18 years of age) 113 
patients who were treated after CA in a tertiary academic hospital between October 2012 114 
and September 2016. Research approval was obtained from the Hospital District of Helsinki 115 
and Uusimaa (HUS/420/2018 25.04.2018).  116 
 117 
Collected data 118 
From the hospital laboratory records, we collected the data of temperature-corrected 119 
PaCO2 samples taken within the first 48 hours of ICU admission. Physiological data, including 120 
respiratory gas values, peripheral oxygen saturation (SpO2), and body temperature at the 121 
time points corresponding to each ABG sampling, were collected from the ICU electronic 122 
patient data management system (Picis, Wakefield, MA, USA). Patient characteristics, such 123 
as age, height, weight, and gender, were collected from the ICU electronic patient data 124 
management system. Comorbidities and resuscitation factors were collected from 125 
electronic patient medical records (Uranus, CGI, Canada). Organ dysfunction and severity of 126 
illness scores (Sequential Organ Failure Assessment [SOFA]; the Simplified Acute Physiology 127 
Score II [SAPS II]); and the Acute Physiology and Chronic Health Evaluation II [APACHE II]) 128 
scores  were retrieved from the Finnish Intensive Care Quality Consortium Database (Tieto 129 





Estimation of arterial CO2 partial pressure  133 
The original formula used for estimating PaCO2 has been published previously  and is defined 134 
as follows: 7 135 
PaCO2-est1= PETCO2+k(PIO2-PETCO2)-PaO2 136 
where PETCO2 is the measured end-tidal CO2 pressure and PIO2 is the measured inspired O2 137 
pressure with the equation of FIO2 x (barometric pressure–saturated vapor pressure of 138 
H2O). PaO2 is estimated from the oxygen dissociation curve. 11 This formula was developed 139 
further in an attempt to improve accuracy. The patient population was divided randomly 140 
into derivation and validation groups. Using linear regression, we used derivation data to 141 
compose the new, calibrated formula and to determine the calibration factors that would 142 
minimize the difference between estimated and measured PaCO2 values.  143 
 144 
Creation of the calibrated, new formula (PaCO2-est2) 145 
 The relationship factors were defined by fitting the data points for the minimal difference 146 
between the blood gas measured PaCO2 and the novel formula estimated value. For this 147 
purpose, 6,580 data points measured from the 233 patients were divided into two groups 148 
according to PETCO2 values. Data points having PETCO2 < 3 kPa were excluded as potentially 149 
artifactual, for example, a leak caused by side-steam gas sampling. The remaining data were 150 
randomly allocated to a derivation group of 50 patients. The remaining 183 patients 151 
composed the validation group. The 1008 data sets of the derivation group were divided 152 
according to a PETCO2 value of 4 kPa. The 4 kPa division value was randomly selected to 153 
reflect potentially major (< 4 kPa) and normal or minor ( 4 kPa) V/Q mismatches that could 154 
result in different relationship factors. We defined different validation coefficients, called k- 155 
factors, for data sets depending on the measured carbon dioxide level, keeping the 4 kPa 156 
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threshold. The potentially major V/Q mismatch group included 255 data sets, and the 157 
potentially normal or minor mismatch group included 753 data sets. The remaining data 158 
sets—3,504 in total—composed the validation group. The study flowchart is presented in 159 
Supplementary Figure 1.  160 
 161 
Using the least square fitting to minimize the difference between the estimated PaCO2 and 162 
ABG PaCO2 values, the equation coefficients were determined for both the major and the 163 
normal or minor V/Q mismatch groups separately. These coefficients were then used to 164 
calculate the estimated PaCO2 for the validation group data points comprising the presented 165 
validation result statistics. The values for the coefficients are presented in Table 1. 166 
After adjustments, the formula (PaCO2-est2) is defined as follows:  167 
 PaCO2-est2=k1*PETCO2+k2*(PIO2-PETCO2)+k3*(100-SpO2) 168 
PaCO2 is the arterial CO2 partial pressure, and PETCO2 and PIO2 are the end-tidal CO2 and 169 
inspired O2 pressures, respectively, recorded with a side-stream gas analyzer (GE 170 
Healthcare, Milwaukee, Wisconsin, USA). SpO2 is the peripheral hemoglobin oxygen 171 
saturation measured with a pulse oximeter.  172 
 The O2 difference in this hypothesis is based on the estimation of PETO2-PaO2 with the aid 173 
of standard bedside monitored parameters. It is well-known that the O2 difference (PIO2-174 
PETO2) is approximately PETCO2, providing an estimate for PETO2 (PIO2-PETCO2). 12  175 
Conceptually, this equation is based on the hypothesis that the physiological factors causing 176 
the alveolar–arterial tension difference are similar for both O2 and CO2: 177 
ventilation/perfusion mismatch in the form of left-to-right shunt perfusion and alveolar 178 




    In shunt perfusion part of the pulmonary artery blood flow is passing the lungs without 181 
communicating with the alveoli. In pulmonary vein this shunted blood of venous O2 content 182 
mix with the blood flow representing alveolar gas composition. Affinity of low oxygen 183 
saturation of the shunted perfusion reduces the mixture oxygen partial pressure from the 184 
alveolar equilibrium. Depending on the shunt, the magnitude of dissolved O2 may be 185 
insufficient to fully saturate the Hb, which is measured as SpO2 below 100%. The difference 186 
(100-SpO2) measures the magnitude of this insufficiency. Clinician may respond to reduced 187 
SpO2 by increasing the PIO2. This compensatory action increases the second term of the 188 
equation.  189 
      In alveolar dead space no gas exchange occurs with the alveolar blood flow, which 190 
reduces SpO2. Thus, increase on the term (100-SpO2) of the equation indicates the increase 191 
in alveolar dead space. Again, clinician may respond to reduced SpO2 by increasing the PIO2 192 
increasing respectively the second term of the equation.  The gas in alveolar dead space 193 
remains in inspired concentrations and dilutes at upper respiratory tract reducing PETCO2. 194 
This increases the second term as indication of the alveolar dead space. In addition to a V/Q 195 
mismatch, possible differences in CO2 and O2 alveolar exchange may cause additional 196 
differences between PETCO2 and PaCO2 not reflected in the O2 difference; for example 197 
diffusion disturbance. Each factor was assigned a relationship coefficient, the values of 198 
which were determined by the calibration data points.  199 
 200 




We divided the 48-hour study period into three-hour intervals; in cases with more than one 203 
sample per three-hour period, we calculated the mean of the differences between the 204 
measured and estimated PaCO2 values.  205 
 206 
Statistical analyses 207 
To validate PaCO2-est1 and the comparisons used between PaCO2-est2 and PETCO2, we 208 
calculated the mean difference with the standard deviation (SD) between the measured and 209 
estimated PaCO2 values. We assessed the agreement between the measured and estimated 210 
PaCO2 values using the Bland-Altman analysis. We used the software created by Olofsen et 211 
al. for the Bland-Altman analysis, including the bias with +/-SE and the limits of agreement 212 
with 95% confidence intervals. 13 Percentage error was calculated from the SD of agreement 213 
and mean CO2: 100* (1,96*SD/mean CO2). 214 
Other analyses were performed using Statistical Package for Social Sciences (SPSS), 215 
version 25 (IBM SPSS Statistics for Macintosh, Version 24.0. Armonk, NY, IBM Corp.). Within-216 
subject (WSV) and between-subject variances (BSV), intraclass correlations (τ), and 217 
repeatability coefficients were estimated for the differences between estimated PaCO2 and 218 
ETCO2. The Bland-Altman method used controls for the effect of repeated measures by 219 
calculating the within-subject and between-subject variations. The normality of the 220 
distribution of the differences between the measured and estimated values was tested 221 
using the Kolmogorov–Smirnov test. 222 
A comparison of the differences between estimations provided by PaCO2-est2 and 223 
PETCO2 was performed using a mixed linear model in which time and measured values were 224 
treated as fixed effects, whereas subjects and formulas were treated as random effects. 225 
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Also, using a mixed linear model, we tested the accuracy of the formulas over time and 226 
whether there was any interaction between the performance of the formulas and the mean 227 
arterial blood pressure or patient temperature. We also examined the accuracy of the 228 
methods in different PaCO2 and O2 levels by dividing the data in deciles, according to the 229 
















In total, we included 233 patients and collected 4,741 datasets. The basic patient 244 
characteristics are shown in Table 2. We excluded two patients because of missing data for 245 
the inspired gas O2 concentrations. The mean number of ABG samples per patient was 15 246 
(SD 10). One of the CAs was in the hospital and the other 232 were out of the hospital. All 247 
patients were treated with therapeutic hypothermia. Table 3 shows the baseline 248 
information about the ventilator parameters and hemodynamics during the 48-hour study 249 
period.  250 
 251 
Difference between the estimated and measured PaCO2 values (PaCO2-est1) 252 
The mean difference between the measured and estimated PaCO2 values (PaCO2= PETCO2+k 253 
PIO2-PETCO2-PaO2) was 0.08kPa (SE ± 0.003). The SD of the differences was 0.62 (SE ± 254 
0.015), percentage error was 24%. The Bland-Altman plot demonstrating the agreement 255 
between the PaCO2-est1 and measured PaCO2 values with limits of agreement and their 95% 256 
confidence intervals is presented in Figure 1. 257 
 258 
Intraclass correlation (PaCO2-est1) 259 
The within-subject variance for the estimated PaCO2 (PaCO2-est1) and measured PaCO2 260 
values was 0.20 (SE ± 0.004). The between-subjects variance was 0.19 (SE ± 0.018). The 261 
intraclass correlations (τ = ratio of BSV and total variance) for the estimated PaCO2 and 262 
measured PaCO2 values were τ 0.48 (SE ± 0.025, Spearman’s ρ -0.105, SE ± 0.029). 263 
 264 




The data for the PaCO2 values were not normally distributed (Kolmogorov–Smirnov test, p 267 
value < 0.001). The mean difference between the measured and PaCO2-est2 values was 268 
0.036 kPa (SE ± 0.009). The SD of the differences was 0.59 (SE ± 0.06), percentage error was 269 
23%. The mean difference between the measured PaCO2 and ETCO2 values was 0.71 kPa (SE 270 
± 0.010), percentage error was 24%. The SD of the differences was 0.62 (SE ± 0.07). There 271 
was a statistically significant difference between PaCO2-est2 and end-tidal CO2 in estimating 272 
PaCO2 (p < 0.001). Also, there was a statistically significant difference (p < 0.001) when 273 
comparing the true and estimated values with the original, unmodified formula (PaCO2-274 
est1) and modified formula (PaCO2-est2). 275 
The Bland-Altman plots demonstrating the agreement between the PaCO2-est2 and 276 
measured PaCO2 values, as well as the PaCO2 (PETCO2) and measured PaCO2 values with 277 
limits of agreement and their 95% confidence intervals, are presented in Figure 2a and 2b, 278 
respectively. The accuracy of the PaCO2-est2 was not affected by the patients’ temperature 279 
(Supplementary Figure 1). There was no statistically significant difference between the 280 
methods at different mean arterial pressure levels (Supplementary Figure 2). PaCO2-est2 281 
was superior to PaCO2-est1a nd end-tidal CO2 at different temperature and blood pressure 282 
levels.  283 
 284 
The effect of time 285 
 286 
The mean difference between the measured PaCO2 values and estimated PaCO2 values in 287 
the first three hours was 0.12kPa (SE +/- 0.041) when using PaCO2-est2. The SD of the 288 
differences was 0.73. The mean difference between the measured and estimated PCO2 289 
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values changed over time according to the linear mixed model analysis. These changes, 290 
however, were not significant (p=0.06). The mean differences between the measured and 291 
estimated PaCO2 levels by both methods—PETCO2 and PaCO2-est2—on three-hour intervals 292 
starting from the first ABG sample are presented in Figure 3. 293 
 294 
The effect of different carbon dioxide and inspired oxygen levels on the accuracy of 295 
PaCO2-est2 296 
Estimations carried out with PaCO2-est2 were the most accurate in normoventilation. The 297 
differences between the measured and estimated PaCO2 in PaCO2 deciles are shown in 298 
Figure 4a. The difference between the measured and estimated PaCO2 values was not 299 
affected by FIO2 values at the same degree as PaCO2 levels. The differences between the 300 
measured and estimated PaCO2 values in FIO2 deciles are shown in Figure 4b.  301 
 302 
The intraclass correlation 303 
The WSV for the estimated PaCO2 and ETCO2 values were 0.16 (SE ± 0.004) and 0.18 SE +/- 304 
0.004), respectively. The intraclass correlations (τ = ratio of BSV and total variance) for the 305 
estimated PaCO2 and PETCO2 values were τ 0.48 (SE ± 0.028, Spearman’s ρ 0.16, SE ± 0.033) 306 












We developed and validated a novel formula that utilizes respiratory gas measurements and 317 
SpO2 for estimating PaCO2 noninvasively in mechanically ventilated patients. We found a 318 
good agreement between measured and estimated PaCO2 values for the novel formula and 319 
found no evidence of impaired accuracy depending on patient temperature and mean 320 
arterial pressure levels. This formula might enable reliable, noninvasive methods for 321 
monitoring mechanical ventilation. The difference between the measured and estimated 322 
PaCO2 values in our study is below the limit of agreement of a clinically acceptable 1 kPa 323 
error.14 324 
In healthy subjects, there is a reasonable agreement between PETCO2 and arterial 325 
PaCO2, especially with temperature corrected PaCO2. 15 -16 By contrast, with respiratory or 326 
cardiac failure, the gap between PaCO2 and ETCO2 widens because of V/Q mismatch, which 327 
results in lower alveolar and expired breathing gas CO2 levels. In some studies, there has 328 
been a strong agreement between PETCO2 and PaCO2. 17-19 Other studies have reported that 329 
the gradient between PETCO2 and PaCO2 has clinically significant importance considering for 330 
example the reliability of monitoring and the adequacy of ventilation.  20-21 In patients with 331 
hypotension and metabolic acidosis, the gap between PETCO2 and PaCO2 is higher than in 332 
normotensive and stable patients. 22 333 
 The accuracy of the novel formula is the highest in the normoventilation range. 334 
Previous studies of end-tidal CO2 and PtcCO2 and show similar results with high PaCO2 levels, 335 
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which can be the result of increased dead space and shunting. 22-23. The method 336 
underestimated the highest PaCO2 values, which may occur with large alveolar dead space. 337 
The PACO2 of perfused alveoli equilibrates with blood concentration  to maximum venous 338 
CO2 concentration independently of the alveolar dead space whereas in the alveolar dead 339 
space the concentration remains zero of the inspired gas. At expiration the  zero 340 
concentration dead space gas dilutes the blood concentration stream from perfused alveoli 341 
causing the PETCO2 reduction corresponding to the amount of dead space ventilation. The 342 
alveolar dead space effect on oxygen is minor: the  PAO2 of the perfused alveoli will 343 
decrease more in supplying the whole perfusion with smaller gas volume. During expiration, 344 
when mixing in the upper airways, the inspired oxygen concentration from the dead space 345 
compensates the reduced PAO2 from the perfused lung regions. As a result of this 346 
compensation in oxygenation, the equation is unable to fully compensate the alveolar dead 347 
space effect on the PaCO2.     348 
  Patient temperatures did not affect the formula’s accuracy. This is important because 349 
patients in prehospital care are more likely to suffer from hypothermia24 and targeted 350 
temperature management is standard practice during the intensive care of patients after 351 
CA.  352 
The mean difference between the measured and estimated values was slightly 353 
higher in the first three hours compared with the remaining 45 hours but this difference was 354 
not statistically significant. In previous studies, the difference between PETCO2 and PaCO2 355 
has been reported to increase over time. 25 356 
There was a statistically significant difference between the PaCO2 estimates 357 
obtained using the two formulas (PaCO2-est1 and PaCO2-est2). An improvement regarding 358 
PaCO2-est2 compared with PaCO2-est1 is that PaCO2-est2 utilizes data directly from the 359 
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pulse oximeter instead of PaO2 estimated by SpO2 obtained from the oxygen dissociation 360 
curve.  361 
 In emergency care despite its unreliability for determining the adequacy of 362 
ventilation26, PETCO2 is a useful tool in verifying the correct positioning of an endotracheal 363 
tube. 27 Transcutaneous CO2 is routinely used in neonatal ICUs. 28 In adults, PtcCO2 has 364 
shown conflicting results29-30 and may be affected by hypotension, peripheral perfusion 365 
disturbances and the use of vasoconstrictors. 31-32 Transcutaneous PCO2 appears to be a 366 
more accurate method compared with PETCO2, but its accuracy might deteriorate with 367 
extreme PaCO2 values and is also affected by V/Q mismatch. 33-34, 23.  368 
There are some limitations to this study. One patient was hemodynamically unstable 369 
and potentially had a very low cardiac output (CO). In conditions associated with low CO, 370 
PETCO2 does not correlate with PaCO2 values, but unfortunately, the CO value was not 371 
available for assessment in this case. 35 Our next aim is to identify the limitations of the 372 
algorithm and validate the formula in different critically ill mechanically ventilated patient 373 
groups. 374 
 375 
 In conclusion the present study shows that a novel formula developed for estimating PaCO2 376 
values has good agreement with measured ABG values and outperforms PETCO2 in 377 
accuracy. Within certain limits, it offers a noninvasive and continuous method for assessing 378 
PaCO2.               379 
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Table 1. Coefficients k1, k2, and k3 for Formula 2 as determined by using 500 randomly 





 k1 k2 k3 
PETCO2-low (<4 kPa) 1.178 0.0132 0.0185 











  522 
Table 2. Characterization of patients and various subgroups of interest 
 
 Patient characteristics  
  Age, years 62 (52-67) 
  Male sex, n (%) 181 (81) 
  Height, cm 179 (172-183) 
  Weight, kg 85 (75-90) 
  
Initial rhythm, n (%)  
  VF 
  VT 
228 (97.9) 
2 (0.85) 
  PEA 2 (0.85) 
  Asystole 1 (0.4) 
  
ROSC, min 20 (15-25) 
  
Scoring model, n (IQR)  
APACHE II 25 (18-31) 
SAPS 47 (35-64) 
SOFA 8 (7-10) 
  
Prevalence of lung disease, no (%)  
  Asthma 18 (7.7) 
  COPD 11 (4.7) 
  Interstitial lung disease 2 (0.85) 
 
 24 
Table 3. Characteristics of ventilation and hemodynamic variables during first and second 523 
intensive care unit (ICU) treatment days. Data are shown as median (interquartile range). 524 
 Day 1 Day 2 
FIO2, % 35 (30-49) 35 (30-45) 
SpO2,% 99 (98-100) 99 (97-99) 
PEEP, cmH2O 7 (6-8) 7 (6-8) 
HR 55 (45-68) 66 (55-79) 
MAP, mmHg 78 (73-86) 77 (72-84) 
PETCO2, kPa 4.2 (3.8-4.7) 4.6 (4.1-5.1) 
PaCO2, kPa 5.0 (4.5-5.4) 5.2 (4.9-5.6) 
PaO2/FIO2-ratio 210 (36-303) 198 (36-310) 
  525 
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Figure 1. The Bland-Altman plot assessing agreement between PaCO2 (PaCO2-est1) and 527 
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 Avarage of PaCO2 and CO2 (PaCO2-est1), kPa
mean= 0.08 kPa
upper LoA (1.3) with 95% Cl
lower LoA (-1.1) with 95% Cl
n=4741 data points




Figure 2a. The Bland-Altman plot assessing agreement between PaCO2 (PaCO2-est2) and 534 
measured PaCO2  535 
 536 
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upper LoA (1.2) with 95% Cl
lower LoA (-0.74) with 95% Cl
n=4512 data points




Figure 2b. The Bland-Altman plot assessing agreement between ETCO2 and measured PaCO2 538 
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upper LoA (2.1) with 95% Cl
lower LoA (-0.2) with 95% Cl
Avarage of PaCO2 and PETO2,  kPa
n=4512 data points




Figure 3. The mean differences between measured PaCO2 and estimated PaCO2, and mean 541 
differences between measured PaCO2 (Formula 2)  and end-tidal CO2 at different time 542 
periods 543 
 544 
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Figure 4a. The mean differences between measured PaCO2 and estimated PaCO2 (Formula 546 
2) , and mean differences between measured PaCO2 and end-tidal CO2 at CO2 deciles 547 
 548 
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Figure 4b. The mean differences between measured PaCO2 and estimated PaCO2 (Formula 550 
2) , and mean differences between measured PaCO2 and end-tidal CO2 at FIO2 deciles 551 
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1. Supplementary Figure 2. The difference between measured and estimated PaCO2 at 558 
different body temperatures. 559 
 560 
  561 
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2. Supplementary Figure 3. The mean differences between measured and estimated 562 
PaCO2 ( Formula 1, Formula 2, and end-tidal CO2) at different mean arterial pressure 563 








Table 2 .Patients’ characteristics and pre-hospital variables. All continuous values are given 570 
as medians (interquartile range), and categorical values as percentages. Cm=centimeters, 571 
kg=kilograms, VF=ventricular fibrillation, VT=ventricular tachycardia, PEA=pulseless 572 
electrical activity, ROSC=Return of spontaneous circulation, COPD= chronic obstructive 573 
pulmonary disease 574 
Table 3. Hemodynamic variables and variables of ventilator settings and derived data. All 575 
continuous values are given as medians (interquartile range). FIO2=fraction of inspired 576 
oxygen, SpO2=partial oxygen saturation of the arterial blood, PEEP=positive end-expiratory 577 
pressure, HR=heart rate, MAP=mean arterial pressure; etCO2=end-tidal carbon dioxide; 578 
PaCO2=arterial partial pressure of carbon dioxide; PaO2/FIO2= arterial oxygen partial 579 
pressure/fractional inspired oxygen ratio 580 
 581 
 582 
Figure 1. Bland-Altman plots with 95% limits of agreement with 95% confidence intervals 583 
demonstrating agreement between partial pressure of carbon dioxide, PaCO2 (Formula 1), 584 
and measured PaCO2 during the first 48 hours after admission to the ICU.  585 
 586 
Figures 2a and 2b. Bland-Altman plots with 95% limits of agreement with 95% confidence 587 
intervals demonstrating agreement between the PaCO2 (Formula 2) and measured PaCO2 588 
values (a) and the ETCO2 and measured PaCO2 values (b) during the first 48 hours after 589 




Figure 3. Mean differences between the measured and estimated PaCO2 values and 592 
between measured PaCO2 and end-tidal CO2 at different time points: First time period: 0–3 593 
hours; 2nd: 3–6 hrs; 3rd 6–9 hrs; 4th 9–12 hrs; 5th 12–15 hrs, 6th 15–18 hrs; 7th 18–21 hrs; 594 
8th: 21–24 hrs; 9th: 24–27 hrs; 10th 27–30 hrs; 11th 30–33 hrs; 12th: 33–36 hrs; 13th: 36–595 
39 hrs; 14th: 39–42 hrs; 15th: 42–45 hrs; and 16th: 45–48 hrs. 596 
 597 
Figures 4a and 4 b. The mean differences between measured PaCO2, estimated PaCO2 598 
(Formula 2) and end-tidal CO2 values at different levels of PaCO2. 1: PaCO2 < 4.3 kPa; 2: 599 
PaCO2 4.3-4.5 kPa; 3: PaCO2 4.6-4.7 kPa; 4: PaCO2 4.8-4.9 kPa; 5: PaCO2 5.0-5.1 kPa; 6: PaCO2 600 
5.2 kPa; 7: PaCO2 5.3-5.4 kPa; 8: PaCO2 5.5-5.6 kPa; 9: PaCO2 5.7-5.9 kPa; and 10: PaCO2 > 601 
5.9 kPa. The mean differences between the measured PaCO2, estimated PaCO2 (Formula 2), 602 
and end-tidal CO2 values at different levels of FIO2 (%). 1: FIO2 < 26; 2: FIO2 26–30; 3: FIO2 603 
30–30.3; 4: FIO2 30.3–34.6; 5: FIO2 34.6–35.2; 6: FIO2 35.2–40.0; 7: FIO2 40.0–45.0; 8: FIO2 604 
45.0–50.33; 9: FIO2 50.33–60.55; and 10 FIO2 > 60.55. 605 
 606 
 607 
Supplementary Figure 1. Flowchart of the study population. V/Q 608 
mismatch=ventilation/perfusion mismatch; ETCO2=end-tidal carbon dioxide; kPa=kilopascal 609 
 610 
Supplementary Figure 2. The difference between the measured and estimated PaCO2 values 611 
at different body temperatures. PaCO2=Partial pressure of arterial carbon dioxide; 612 




Supplementary Figure 3.  The mean differences between the measured and estimated 615 
PaCO2 values (Formula 1, Formula 2, and end-tidal CO2) at different mean arterial pressure 616 
levels. PaCO2=Partial pressure of arterial carbon dioxide; ETCO2=end-tidal carbon dioxide. 617 
 618 
 619 
 620 
